Pamicogrel is a cyclooxygenase inhibitor that was under development for its anti-platelet-aggregation effects.[1][2]

References

  1. ^ Light P (September 1999). "Pamicogrel (Kanebo)". IDrugs. 2 (9): 938–42. PMID 16121308.
  2. ^ "Pamicogrel inhibits platelet aggregation". Inpharma Weekly. 1272 (1): 11. January 2001. doi:10.2165/00128413-200112720-00021. S2CID 195132149.

External links